Online Calculator May Predict Treatment-Related Hearing Loss in Children With Cancer
The dose of chemotherapy and radiation, patient age, and timing of treatment were all associated with the risk of severe hearing loss.
Head and Neck Cancer News
HEAD AND NECK CANCER ADVISOR
Head and Neck Cancer News
Data Hide ‘Critical Disparities’ in Nasopharyngeal Carcinoma Incidence Among Asian Americans
The incidence was highest among Laotian and Chinese Americans.
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
Reductions in oropharynx cancer incidence should be seen among young and middle-aged adults.
No Survival Benefit With Nivolumab Plus Ipilimumab in R/M Head and Neck Squamous Cell Carcinoma
The phase 3 CheckMate 651 trial showed prolonged overall survival and durable responses in specific subsets of patients.
Avelumab Doesn’t Improve Upon Standard Care for Head and Neck Cancer
Avelumab plus cetuximab and radiotherapy did not improve progression-free survival over standard care in cisplatin-fit or -unfit patients.
Gemcitabine Plus Cisplatin Improves Overall Survival in Advanced Nasopharyngeal Carcinoma
Gemcitabine plus cisplatin reduced the risk of death by 28%.
New Therapies on the Horizon for Elderly or Frail Patients With Head and Neck Cancer
A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.
Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors
Response endpoints were not strongly correlated with overall survival at the trial level.
Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening
The test can accurately detect cancer and predict where it is located, according to researchers.
Patient Perception of Outcomes Associated With Psychosocial Function After Reconstruction for Head and Neck Cancer
Survey-based study determined the association between patients’ perception of aesthetic outcome and psychosocial function after undergoing ablation with this complex procedure.
Lobaplatin-Based Regimen May Be ‘Promising’ Alternative for Nasopharyngeal Carcinoma
Treatment-related toxicities were less likely with the lobaplatin-based regimen.
Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care
Findings suggest a need for tailored treatment in oropharyngeal squamous cell carcinoma.
Camrelizumab Plus Chemo Could Be New Standard for Recurrent, Metastatic Nasopharyngeal Carcinoma
The combination significantly prolonged progression-free survival.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...